Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
This would directly help molten ventures obtain a price closer to fair value
https://www.theguardian.com/politics/2024/feb/09/jeremy-hunt-may-launch-british-isa-investing-in-uk-company-shares?CMP=Share_AndroidApp_Other
True but if you have valuable ip in the worlds hottest new economic sector needed funding will find a way. might not be a classic funding round. maybe merger of some description.
ive not heard of recent staff reductions/defections so staff think worth hanging about in spite of extreme personal marketability right now.
You could have the most valuable IP in the world but if you have no funds to exploit it....
Good point, I guess it depends on how much the pre-funding valuation is (i.e. the current IP value) but if low then agree that MV likely to be wiped out!
Steph I have said this before.
Graphcore say they need 1bn to keep going until 2027 as that is when they hope to generate significant revenue.
Molten are unlikely to commit more as to play it would mean stumping up a lot of cash.
So if a raise at that scale took place it would wipe out Molten's position through massive dilution.
That is why Sequoia wrote it down to zero on their books.
I assume he has the funding needed sewn up if he has time for a tour
Yep and he's off on a tour to promote it.
His book has just come out:
https://www.eenewseurope.com/en/how-ai-thinks-brings-ai-to-the-people/
Nigel Toon gave up a while back and has spent the last 18 months writing a book, which he wouldn't have had time to do if he was busy running a successful business.
Steph, please Graphcore is dead. If it has no money their tech will be bought from the administrators.
The article has been generated by AI and offers no reference whatsoever for the claim that Graphcore is in a position to compete with Nvidia.
There are other companies in the portfolio that have much better prospects.
“Also, Nvidia faces more competition from AI chip startups Cerebras, Sambanova and Graphcore”
https://www.investors.com/news/technology/artificial-intelligence-stocks/
At least Graphcore gets a mention as in the ring. Graphcore is down to only 21.3 m on our books from 113m March 2022. From there centre of gravity is almost certainly upside. Only needs to be bought out for it’s IP and staff to be worth more than our 21m. Even remotely as a going concern able to take on NVIDIA and it will be worth many times what we currently have it on our books for.
Sang thanks
“Median seed pre-money valuation up 33% in past two years“
https://files.pitchbook.com/website/files/pdf/2023_Annual_US_VC_Valuations_Report.pdf
Our pre seed and seed funds have not been by necessity written down and yet we have a bigger discount to funds that have no seed. Makes little sense to me.
YOur benchmarking of Aiven with Confluent welcome. We actually sold around 10m pounds worth of Aiven on the market in the last half so our NAV on the reminder (83.1m) on that is recently tested and solid.
I also have a much better feeling about Coachhub. Their strategy was to go for big logo wins and it seems to be paying off with recent client wins like Amazon, Booking.com, easyJet, Virgin Atlantic, Cemex and Schneider Electric.
One of the biggest holdings is Aiven. The most recent NAV of 730 has them written down to a value of about 2.4bn dollars. This could still be a bit high but maybe not by that much.
They have a publicly listed comparator in Confluent. At peak bubble they were valued at close to 30bn but are now down to 8bn. This is on a multiple of about 12 of sales to price.
Both companies deliver data infrastructure services on the cloud, and cloud companies were battered a year or so back but cloud spend has been recovering fairly rapidly and their is an additional use case for their services involving streaming data from Generative AI.
Aiven posted revenue of 67m Euro for 2022 but this was almost double the previous year. So I think it's fair to assume 100m plus dollar revenue for 2023. So a multiple of 12 to that would give value of 1.2bn so contribute to a NAV of 365.
Confluent is still seen as suffering from market lack of confidence in small cap tech stocks. Once they break even they could get back over 10bn, which would again make Aiven's valuation seem a lot more realistic.
As would Aiven getting revenue closer to 200bn
Director buys and no director sells a good thing.
Also means there is no take private or take over in the works or they would not be allowed. I fear either as it would lock in our low price in exchange for a minor SP boost of 50% or so. I am holding all until at least a 500% boost and expect that within 3 years if not sooner.
"Another manager has chucked £50K into the hat."
So is that 'incidental' - or maybe a vote of confidence?!
Another manager has chucked £50K into the hat.
For my money I think the NAV/share is accurate and the market for late round fundraising and IPO’s will in due course confirm. Ambiguity and thus suspicion on valuations without market price discovery is overdone.
As soon as a representative sample of our core portfolio achieves fund raising at NAV’s at or above what they are on the MV books for we will soar fast. All fundraising thus far has been at or above our NAV assumed. There is no evidence of the discount the SP assumes is needed.
Anyhow big gains for the patient investor here. 4x over a 2 year horizon quite doable.
Sangijuelas, I do accept that there are many Investment Trusts (IT) that hold listed equities, however, III, PEY and AUGM, which are among the IT which I hold are principally comprised unlisted companies though at different stage of life. If we accept that investing in seed and fledgling companies need very different resource from those which are at the stage to either be spun off as a quoted company or divest to the needs appropriate to the development of that business.
Some businesses require cash, others need introductions to build sales and some need skilled people for compliance.
As far as I am concerned, my cash investment in GROW would, if the IT were wound up tomorrow probably be completely worthless if bean counters from an insolvency outfit were engaged. On the other hand, GROW has a stake in plenty of companies and perhaps a few will be a runaway success in time. It is a risk that I am prepared to take. As a general rule, I tend to comment publicly where I am worried or find the quality of discussion does not merit engagement. (AFC, EZJ, BEG for instance).
There is still 100% for the share price to fall. My hunch is that the NAV is overstated as far as the broad investing community is concerned. That the managers have dipped into their pockets to buy shares, is incidental.
All similar vehicles are on massive discounts to the valuations of unlisted / listed / cash holdings.
IP group has cash at half its value, listed assets and listed assets probably then at 25%, ARIX until recently had the unlisted elements as a free ride, shellalion was until recently on a 60% plus discount.
Need the ipo market to improve and see assets floated at the values they are in the books. Also biotech needs to rerate.
Alas, most investment trusts hold listed equities so price discovery of the assets is a constant.
Here the valuations making up the NAV are based on funding rounds and comparisons with similar companies that are listed. So a much higher degree of subjectivity involved.
The fact that two of the MV Directors recently bought shares should give us some confidence in the company - or at least I hope so!
It is always disheartening when the value of an investment falls, more so when there is a chasm between the value of the underlying assets and the market capital of the holding company. It is not unusual for a small discount or premium to apply from time to time from MOST investment trusts, and, for the most part such variation tends to be in the region of 5% premium and 12%-15% discount.
Anything outside these figures generally merits investigation. More often than not, the gap closes to be in the range noted above. If the underlying valuation is wrong, it will distort the numbers. If the managers have a poor track record, then that will put pressure on the discount. Investment trust managers can (and often do) buy shares in the market and hold them in treasury to take advantage of unusual gaps and sell them at a later date when the price benefits the company.
My hunch is that there is insufficient cash to allow the trust to buy shares in the market and take advantage of the discount and that there is an institutional holder that is dumping their holding. I'm not convinced that the valuation is correct. The managers might have have stretched their rope a little too much and be close to breaking point. If the valuations are broadly correct and an institutional holder is really upset, it is possible that the Trust could be wound up to put an end to the miserable share price performance. Panic does not help in a decision making process but speculation can be beneficial.
Of course, this is not a holding for widows and orphans. Just the musings of an old duffer, so take with a scoop of salt.
And me - I've bought some more too! I cannot understand the SP as long as we're comfortable that the NAV is reasonably well supported. Presumably some of the Forward Ventures lot might be "cashing out"? Private Equity is a long term play but has the best long term returns - it just might be the last fund I sell in my portfolio!
Well I did go ahead and bought a few more MV shares...